Triple-Negative Breast Cancer (TNBC) is a highly heterogeneous disease defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and the lack of overexpression of human epidermal growth factor receptor 2 (HER2)1–3. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.